(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Myelofibrosis pipeline constitutes 45+ key companies continuously working towards developing 45+ Myelof… Read More

DelveInsight’s “Follicular Lymphoma Market Insights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding of the Follicular Lymphoma, historical… Read More

The US Food and Drug Administration (FDA) has granted approval to Ojjaara (momelotinib), a Janus kinase (JAK) inhibitor by GlaxoSmithKline (GSK), as the primary treatment for adults with int… Read More

In a world where health is paramount, the pharmaceutical industry stands as a formidable pillar, relentlessly pursuing scientific breakthroughs and life-saving innovations. With each passing… Read More

DelveInsight’s report titled “Neurofibrosarcoma Pipeline Insight 2023” offers extensive information on more than 15+ companies and over 15+ pipeline drugs in the field of… Read More

The myelofibrosis market overview provides an analysis of the pharmaceutical and therapeutic landscape related to the diagnosis, treatment, and management of myelofibrosis. Myelofibrosis is… Read More

, /PRNewswire/ -- The tyrosine kinase inhibitors market size is expected to grow by USD 19.07 billion from 2021 to 2026. In addition, the growth momentum of the market will accelerate at… Read More

DelveInsight’s, “Glioma Pipeline Insight, 2022,” report provides comprehensive insights about 150+ companies and 150+ pipeline drugs in Glioma pipeline landscape. It cover… Read More

DelveInsight’s, “Liver Cancer Pipeline Insight, 2022,” report provides comprehensive insights about 75+ companies and 75+ pipeline drugs in Liver Cancer pipeline landscape… Read More

The Inflammatory Bowel Disease (IBD) Treatment market was valued at USD 15.87 billion by 2023, growing with 4.1% CAGR during the forecast period, 2023-2033. Market Dynamics… Read More

, /PRNewswire/ -- Sumitomo Pharma Oncology, Inc., a clinical-stage company focused on novel cancer therapeutics, today presented new data from the ongoing Phase 1/2 study evaluating TP-36… Read More

First In Human is a biotech-focused podcast that interviews industry leaders and investors to learn about their journey to in-human clinical trials. Presented by Vial, a tech-enabled&nb… Read More

Source: Dr. Joseph Pantginis  (10/12/22) With this and other clinical studies, the U.S. company has a busy and, thus, catalyst-rich Q4/22 ahead, noted an H.C. Wainwright & Co… Read More

The development program for at least one of the of the Gastroenterology CRO agents that I’m aware of was stop, which I’m not sure why. There’s not a very robust active pipe… Read More

Serine/threonine-protein kinases (EC 2.7.11.1) are enzyme or protein that has hydroxyl (OH) group in the side chain. Phosphorylation in serine or threonine residues may cause changes in the… Read More

Janus Kinase (JAK) Inhibitors Pipeline to Witness Significant Growth due to Positive Clinical Results in the Coming Years Read More

The study analyzed that the CDK inhibitors therapeutics pipeline comprises approximately 24 drug candidates in different stages of development. CDKs are the catalytic subunits of serine or… Read More

MEK inhibitors market provides details of market share, new developments and product pipeline analysis, impact of domestic and localized market players, analyses opportunities in terms of em… Read More

In 2017, the global Fibrosarcoma Drugs Market was worth $703 million. During the forecast period, it is expected to grow at an annual rate of 8.5 percent. Some of the main factors driving ma… Read More

Image for Illustration purposesMega Doctor News By University of Texas M. D. Anderson Cancer Center  Newswise — HOUSTON and CAMBRIDGE, Mass. ― The University… Read More

Edmonton, Alberta and Austin, Texas--(Newsfile Corp. - June 2, 2021) - To view the full announcement, including downloadable images, bios, and more, click here. Key Takeaways: Cl… Read More

geralt / Pixabay President Trump released from hospital after COVID-19 diagnosis; doctors add steroid used in treating more severe patients. President Trump, eager to demonstrate that his co… Read More

Buy Now According to the report analysis, ‘Colorectal Cancer Therapeutics In Asia-Pacific Markets To 2024 – Launch Of Premium Targeted Therapies And Increasing Prevalence To Driv… Read More

InspiredImages / Pixabay FDA ROUNDUP: In one of the busiest rulings binges of the year, the US Food and Drug Administration last week approved an assortment of pharmaceuticals, medical devic… Read More